SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

BioCryst to Report Q3 2026 Results on Nov. 4

BioCryst Pharmaceuticals will report its third-quarter 2026 financial results on Nov. 4, 2026, and host a call and webcast at 8:30 a.m. ET.

BCRX

BioCryst Pharmaceuticals said it will report third quarter 2026 financial results on Nov. 4, 2026. The company will host a call and webcast at 8:30 a.m. ET.